{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:58:29Z","timestamp":1763765909241,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/pat.0b013e32834e8e5b","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T04:28:45Z","timestamp":1324528125000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers"],"prefix":"10.1016","volume":"44","author":[{"given":"J.L.","family":"Hopper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.","family":"Dowty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.S.","family":"Dite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Apicella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Win","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rosty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Baglietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Severi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dobrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Winship","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Ramus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.G.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Southey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes","volume":"86","author":"Antoniou","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0010","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1054\/bjoc.2000.1520","article-title":"Population carrier frequency of hMSH2 and hMLHl mutations","volume":"83","author":"Dunlop","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-10-0345","article-title":"The search for unaffected individuals with Lynch syndrome: do the endsjustify the means?","volume":"4","author":"Hampel","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0020","first-page":"1059","article-title":"Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families","volume":"60","author":"Levy-Lahad","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1","article-title":"Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary","volume":"86","author":"Van Der Looij","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0030","first-page":"6991","article-title":"Age-related hypermethylation of the 5\u2032 region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development","volume":"61","author":"Nakagawa","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0035","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0045","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0055","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cgh.2006.01.002","article-title":"Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study","volume":"4","author":"Jenkins","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0065","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1200\/JCO.2005.04.671","article-title":"Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer","volume":"23","author":"Southey","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0070","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","article-title":"Feasibility of screening for Lynch syndrome among patients with colorectal cancer","volume":"26","author":"Hampel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cgh.2010.10.021","article-title":"Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer","volume":"9","author":"Limburg","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","article-title":"Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer","volume":"118","author":"Jarvinen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0085","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-010-0894-z","article-title":"Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation andmastectomy","volume":"121","author":"Pierce","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0095","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMc072301","article-title":"Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations","volume":"357","author":"Goodwin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0105","article-title":"Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an international prospective breast cancer family registry population-based cohort study","volume":"29","author":"Goodwin","year":"2011","journal-title":"J Clin Oncol"},{"issue":"15 Suppl","key":"10.1097\/PAT.0b013e32834e8e5b_bib0110","first-page":"1500","volume":"29","author":"Phillips","year":"2011","journal-title":"ASCO Meeting Abstracts"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/gut.2010.228056","article-title":"Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery","volume":"60","author":"Parry","year":"2011","journal-title":"Gut"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnci\/djr153","article-title":"DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracilbased adjuvant therapy","volume":"103","author":"Sinicrope","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jnci\/95.6.448","article-title":"Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations","volume":"95","author":"Dite","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","article-title":"Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics","volume":"45","author":"Antoniou","year":"2008","journal-title":"J Med Genet"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/annonc\/mdn686","article-title":"A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers","volume":"20","author":"Pouchet","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0140","article-title":"Evaluation of predictive models for the identification in daily practice of patients with lynch syndrome","author":"Tresallet","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0145","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-139-12-200312160-00005","article-title":"Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer","volume":"139","author":"Imperiale","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jclinepi.2003.08.013","article-title":"Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk","volume":"57","author":"Kim","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0155","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.canep.2010.04.021","article-title":"10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men","volume":"34","author":"Ma","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0160","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1200\/JCO.2008.17.4813","article-title":"Validation of a colorectal cancer risk prediction model among white patients age 50 years and older","volume":"27","author":"Park","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0165","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1200\/JCO.2005.05.032","article-title":"First Amsterdam, then Bethesda, now Melbourne?","volume":"23","author":"Lenz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2006.02549.x","article-title":"Classification of colorectal cancer based on correlation of clinical, morphological and molecular features","volume":"50","author":"Jass","year":"2007","journal-title":"Histopathology"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2007.04.044","article-title":"Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a populationbased study","volume":"133","author":"Jenkins","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10689-007-9124-1","article-title":"Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary nonpolyposis colorectal cancer","volume":"6","author":"Loughrey","year":"2007","journal-title":"Fam Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0185","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/bcr2476","article-title":"Familial relative risks for breast cancer by pathological subtype: a population-based cohort study","volume":"12","author":"Mavaddat","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","article-title":"Optimal selection of individuals for BRCA mutation testing: a comparison of available methods","volume":"24","author":"James","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0195","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0200","first-page":"782","article-title":"The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2","volume":"6","author":"Lakhani","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0205","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","article-title":"The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study","volume":"83","author":"Armes","year":"1998","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0210","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0215","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.2011.41","article-title":"Morphological predictors of BRCA1 germline mutations in young women with breast cancer","volume":"104","author":"Southey","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0220","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N","article-title":"Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up","volume":"40","author":"Ridolfi","year":"1977","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pas.0000213351.49767.0f","article-title":"BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays","volume":"31","author":"Bane","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1940-6207.CAPR-10-0212","article-title":"Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer","volume":"4","author":"Wong","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"year":"2001","series-title":"Clinical Practice Guidelines for the Management of Early Breast Cancer","key":"10.1097\/PAT.0b013e32834e8e5b_bib0235"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0240","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/0016-5085(91)90666-9","article-title":"Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage","volume":"100","author":"Petersen","year":"1991","journal-title":"Gastroenterology"},{"year":"2004","series-title":"The National Breast Cancer Centre Annual Report 2003-2004","key":"10.1097\/PAT.0b013e32834e8e5b_bib0245"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/GIM.0b013e3181cd666c","article-title":"The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer","volume":"12","author":"Mvundura","year":"2010","journal-title":"Genet Med"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0255","unstructured":"Royal College of Pathologists of Australasia (RCPA). Published protocols. 2011 (cited Aug 2011). http:\/\/www.rcpa.edu.au\/Publications\/StructuredReporting\/CancerProtocols.htm"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0260","doi-asserted-by":"crossref","first-page":"R375","DOI":"10.1186\/bcr801","article-title":"The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer","volume":"6","author":"John","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0265","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1158\/1055-9965.EPI-07-0648","article-title":"Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer","volume":"16","author":"Newcomb","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0270","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1377","article-title":"Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource","volume":"8","author":"Mann","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0275","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral contraceptives and breast cancer risk in the international BRCA1\/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group","volume":"25","author":"Brohet","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0280","doi-asserted-by":"crossref","first-page":"x","DOI":"10.1002\/ijc.24173","article-title":"Molecular screening of all colorectal tumors diagnosed before age 50 years followed by genetic testing efficiently identifies Lynch syndrome cases","volume":"124","author":"Jenkins","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0285","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.296.12.1479","article-title":"Prediction of germline mutations and cancer risk in the Lynch syndrome","volume":"296","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0290","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jnci\/djp473","article-title":"Risks of Lynch syndrome cancers for MSH6 mutation carriers","volume":"102","author":"Baglietto","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e32834e8e5b_bib0295","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","article-title":"The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations","volume":"135","author":"Senter","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516325776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516325776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:17:53Z","timestamp":1758471473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516325776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0031302516325776"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e32834e8e5b","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0b013e32834e8e5b","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}